Pancuronium bromide: a review of its pharmacological properties and clinical application.
D000731:Androstanes; D000777:Anesthetics / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D004357:Drug Synergism; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007441:Intubation, Gastrointestinal; D007700:Kinetics; D008107:Liver Diseases; D009388:Neostigmine / Q000494:pharmacology; D009467:Neuromuscular Depolarizing Agents; D009469:Neuromuscular Junction / Q000187:drug effects; D003473:Neuromuscular Nondepolarizing Agents; D010197:Pancuronium / Q000008:administration & dosage / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D011247:Pregnancy; D013514:Surgical Procedures, Operative; D013997:Time Factors
D000731:Androstanes; D000777:Anesthetics; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D009388:Neostigmine; D001285:Atropine; D010197:Pancuronium